Method for inactivating gonadotrophs
AssigneeColorado State University Research Foundation
InventorsTorrance M. Nett, Leonard Michael Glode, Maciej Wieczorek, Paul J. Jarosz
Life of this patent
Estimating the term…
Loading patent…
AssigneeColorado State University Research Foundation
InventorsTorrance M. Nett, Leonard Michael Glode, Maciej Wieczorek, Paul J. Jarosz
Estimating the term…
Certain toxic compounds (T) such as, for example, compounds based upon diphtheria toxin, ricin toxin, pseudomonas exotoxin, α-amanitin, pokeweed antiviral protein (PAP), ribosome inhibiting proteins, especially the ribosome inhibiting proteins of barley, wheat, corn, rye, gelonin and abrin, as well as certain cytotoxic chemicals such as, for example, melphalan and daunomycin can be conjugated to certain analogs of gonadotropin-releasing hormone to form a class of compounds which, when injected into an animal, destroy the gonadotrophs of the animal's anterior pituitary gland. Hence such compounds may be used to sterilize such animals and/or to treat certain sex hormone related diseases.
A method for sterilizing a mammal, said method comprising administering an effective amount of a conjugate compound comprised of a peptide hormone selected from the group consisting of a GNRH analog (GnRH-A), a human chorionic gonadotropin, an equine chorionic gonadotropin, a luteinizing hormone or a follicle—stimulating hormone which is conjugated to a toxin selected from the group consisting of those plant toxins or bacterial toxins having a toxic domain and a translocation domain and wherein said conjugate compound is capable of binding with a receptor cell of the mammal's pituitary gland and direct chemical attack upon cells of said pituitary gland.
A method for sterilizing a mammal, said method comprising administering an effective amount of a conjugate compound comprised of a peptide hormone selected from the group consisting of a GnRH analog (GnRH-A), a human chorionic gonadotropin, an equine chorionic gonadotropin, a luteinizing hormone and a follicle—stimulating hormone which is conjugated to a toxin selected from the group consisting of those plant toxins:
A method for sterilizing a mammal, said method comprising administering an effective amount of a conjugate compound having the general formula:
A method for sterilizing a mammal, said method comprising administering an effective amount of a conjugate compound having the formula:
A method for treating a sex hormone related disease in a mammal, said method comprising 30 administering an effective amount of a conjugate compound comprised of a peptide hormone selected from the group consisting of a GnRH analog (GnRH-A), a human chorionic gonadotropin, an equine chorionic gonadotropin, a luteinizing hormone or a follicle—stimulating hormone which is conjugated to a toxin selected from the group consisting of those plant toxins or bacterial toxins having a toxic domain and a translocation domain and wherein said conjugate compound is capable of binding with a receptor cell of the mammal's pituitary gland and direct chemical attack upon cells of said pituitary gland.
A method for sterilizing a mammal, said method comprising administering an effective amount of a conjugate compound comprised of a peptide hormone selected from the group consisting of a GnRH analog (GnRH-A), a human chorionic gonadotropin, an equine chorionic gonadotropin, a luteinizing hormone and a follicle—stimulating hormone which is conjugated to a toxin selected from the group consisting of those plant toxins:
A method for treating a sex hormone related disease in a mammal, said method comprising administering an effective amount of a conjugate compound having the general formula:
A method for treating a sex hormone related disease in a mammal, said method comprising administering an effective amount of a conjugate compound having the formula:
Dependencies are inferred from the claim text.